Toren Finkel received his undergraduate degree in Physics and his combined MD and PhD degree from Harvard Medical School in 1986. Following a residency in Internal Medicine at the Massachusetts General Hospital, he completed a fellowship in Cardiology at the Johns Hopkins School of Medicine. In 1992, he accepted a position within the Intramural Research Program of the National Heart, Lung and Blood Institute (NHLBI) at the National Institutes of Health in Bethesda, Maryland. In 2001 he became the Chief of the Cardiology Branch and in 2010 he assumed the position as Chief of the newly formed Center for Molecular Medicine within the NHLBI. His work has revealed a role for endogenously produced reactive oxygen species as modulators of normal signal transduction pathways. His current research interests include the role of reactive oxygen species in aging and stem/progenitor cell dysfunction in age-related diseases.
« Go Back